Eskisehir Osmangazi University, abbreviated as ESOGU, is located in Eskişehir, in the Eskişehir Province of Turkey.

During the past decade, Eskisehir Osmangazi University conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 2 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 1 clinical trials were completed. i.e. 7.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Eskisehir Osmangazi University" #1 sponsor was "Eskisehir Osmangazi University" with 17 trials, followed by "Amgen" with 2 trials sponsored, "Celgene" with 1 trials sponsored, "DILEK SAYIK" with 1 trials sponsored and "Emergency Medicine Association of Turkey" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Eskisehir Osmangazi University" #1 collaborator was "Eskisehir Osmangazi University" with 1 trials as a collaborator, "TC Erciyes University" with 1 trials as a collaborator and "The Scientific and Technological Research Council of Turkey" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Eskisehir Osmangazi University" are "Behcet Syndrome" (2 trials), "Pain, Postoperative" (2 trials), "Alzheimer Disease" (1 trials), "Anti-Bacterial Agents" (1 trials) and "Anxiety" (1 trials). Many other conditions were trialed in "Eskisehir Osmangazi University" in a lesser frequency.

Most popular intervention types in "Eskisehir Osmangazi University" are "Other" (12 trials), "Drug" (7 trials), "Behavioral" (3 trials), "Procedure" (3 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "No intervention" (2 trials), "Placebo" (2 trials), "Apremilast" (1 trials), "Apremilast (CC-10004)" (1 trials) and "Biocompatibility of calcium silicate cements" (1 trials). Other intervention names were less common.

The vast majority of trials in "Eskisehir Osmangazi University" are 25 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Eskisehir Osmangazi University". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Eskisehir Osmangazi University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Eskisehir Osmangazi University, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 12 trials that are defined as “Not Applicable".

Eskisehir Osmangazi University has several departments that took part in Clinical trials: "ESOGU Medical Faculty Department of Chest Diseases" - 2 trials, "Eskisehir Osmangazi University Gastroenterology" - 2 trials